Last reviewed · How we verify
NCT01570010: CRC-NORDIET
The Norwegian Dietary Guidelines and Colorectal Cancer Survival Study
NA trial testing Norwegian food based dietary guidelines in Colorectal Cancer in 503 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2034
Quick facts
| Lead sponsor | University of Oslo |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 503 |
| Start date | 1 March 2012 |
| Primary completion | 31 December 2034 |
| Estimated completion | 31 December 2040 |
| Sites | 3 locations across Norway |
Drugs / interventions tested
- Norwegian food based dietary guidelines
Conditions studied
- Colorectal Cancer — all drugs for Colorectal Cancer →
Sponsor
University of Oslo
Who can join
Adults 50 to 80, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current study is designed to gain a better understanding of the role of a healthy diet aimed at dampening inflammation and oxidative stress on long-term disease outcomes and survival in colorectal cancer patients. Since previous research on the role of diet for colorectal cancer survivors is limited, the study may be of great importance for this cancer population.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: a food-based multicentre randomized controlled trial.
Henriksen HB, Ræder H, Bøhn SK, Paur I, et al · · 2017 · cited 27× · PMID 28137255 · DOI 10.1186/s12885-017-3072-4 -
Relative validity of a short food frequency questionnaire assessing adherence to the Norwegian dietary guidelines among colorectal cancer patients.
Henriksen HB, Carlsen MH, Paur I, Berntsen S, et al · · 2018 · cited 23× · PMID 29545734 · DOI 10.29219/fnr.v62.1306 -
Validation of two short questionnaires assessing physical activity in colorectal cancer patients.
Henriksen HB, Berntsen S, Paur I, Zucknick M, et al · · 2018 · cited 12× · PMID 29854408 · DOI 10.1186/s13102-018-0096-2 -
Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) cancer prevention recommendations with stages of colorectal carcinogenesis.
Kvaerner AS, Andersen AR, Henriksen HB, Knudsen MD, et al · · 2023 · cited 5× · PMID 37212529 · DOI 10.1002/cam4.6119 -
How many days of continuous physical activity monitoring reliably represent time in different intensities in cancer survivors.
Western B, Demmelmaier I, Vistad I, Hansen BH, et al · · 2023 · cited 4× · PMID 37093874 · DOI 10.1371/journal.pone.0284881 -
Plant-based diet and oxidative stress-induced DNA damage in post-surgery colorectal cancer patients: Results from a randomized controlled trial.
Nordengen AL, Krutto A, Kværner AS, Alavi DT, et al · · 2025 · cited 2× · PMID 40180023 · DOI 10.1016/j.freeradbiomed.2025.03.047 -
Predictive equations commonly used in the clinic underestimate resting energy expenditure compared with whole-room indirect calorimetry in colorectal cancer survivors.
Eklo RR, Alavi DT, Konglevoll DM, Kolle Å, et al · · 2026 · PMID 41611086 · DOI 10.1016/j.ajcnut.2026.101209 -
Spillover effect of a dietary intervention on physical activity in a randomized controlled trial with colorectal cancer patients.
Henriksen HB, Kolle Å, Stenling A, Paur I, et al · · 2025 · PMID 40346639 · DOI 10.1186/s12966-025-01757-0
Verify or expand the search:
- PubMed search for NCT01570010
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Cancer
Currently open trials in the same condition.
- NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
- NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
Other University of Oslo trials
Trials by the same sponsor.
- NCT07346911 — Digital Interventions for Relapse Prevention in Adolescence · NA · not yet recruiting
- NCT07499219 — Preliminary Testing and Development of a Short Digital Intervention for Patients on Waiting Lists for Psychological Trea · NA · not yet recruiting
- NCT07408687 — Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - V · NA · not yet recruiting
- NCT07287072 — Pain Reprocessing Therapy for Chronic Primary Pain · NA · not yet recruiting
- NCT07428694 — From Bench to Bedside: A Machine Learning Tool for the Detection of Inspiratory Leak · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01570010 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oslo
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01570010.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing